Global Entrepreneurship Summit: Showcasing American Women in Business

By Christopher A. Garcia
Acting National Director
National Deputy Director
U.S. Department of Commerce
Minority Business Development Agency

November 28, 2017

Earlier this year, The President Trump and Indian Prime Minister Narendra Modi announced that the U.S. and India would co-host the 2017 Global Entrepreneurship Summit (GES) in Hyderabad City, India Nov. 28-30. The GES is an annual event that draws high-level investors, entrepreneurs and business leaders from around the world. It also provides phenomenal opportunities for professional networking, mentoring, and training intended to help entrepreneurs create new products and services that will transform the world we live in.

The 2017 theme, “Women First, Prosperity for All,” will spotlight the important role that women play in fostering global growth and prosperity.  Women leaders and business owners are critical to the economic development and success of our Nation in both the national and international marketplaces. America has more than 11 million women-owned businesses that employ nearly 9 million people and generate more than $1 trillion in revenue. First Daughter Ivanka Trump will lead the American delegation during this year’s summit. A live stream of select sessions can be viewed here.

Prior to my presidential appointment and joining the U.S. Department of Commerce, I was invited by The White House to speak at the GES in Nairobi, Kenya in 2015. In front of a crowd of more than 1,000 entrepreneurs from around the world, I discussed the importance of entrepreneurship in both developed and developing economies. It was a dynamic experience both personally and professionally, and I’m excited to be able to continue that work here at the Minority Business Development Agency (MBDA).

As an alumnus of the Global Entrepreneurship Summit, I’m proud to support both this year’s event and the White House’s efforts to expand opportunities for women entrepreneurs and empower American businesses. One of this Administration’s top priorities is ensuring that entrepreneurs have fair and equal access to the capital, markets, and networks they need to start their businesses, create innovative products and services, and export them around the world.  Through MBDA’s expansive network of strategic partners and stakeholders such as Essence Communications, Inc., Walker’s Legacy, National ACE, and The Latino Coalition, MBDA ensures that women of color have fair and equal access to business development resources and the technical expertise they need to grow their businesses all over the world.

As we close out National Entrepreneurship Month,let us recommit to seizing every opportunity available to showcase the best of America’s entrepreneurial spirit and promote home-grown ingenuity.

For more details on the GES, please visit https://www.ges2017.org/

Regeneca Worldwide, a Division of Vivaceuticals, Inc., Issues a Nationwide Recall of Its Products

March 9, 2017

Regeneca Worldwide, a division of VivaCeuticals, Inc. is conducting a nationwide recall of its entire line of herbal and dietary supplement products pursuant to a Consent Decree entered by the federal court for the Central District of California. This recall applies to all products manufactured and sold between June 1, 2011 and February 8, 2017. These products include, but are not limited to RegeneSlim, RegenErect, RegeneArouse, RegeneBlend, RegeneBoost, RegeneBlast, and RegeneFit. ALL LOT #s ARE INCLUDED IN THIS RECALL. Regeneca products were sold nationwide online using the company’s websites, and through a direct sales force within the United States and Puerto Rico for both consumption and retail sales.

The company has presently ceased doing business in the United States.

Consumers who have purchased Regeneca products subject to this recall are advised to immediately stop using the product and are urged to return it to the place of purchase for a possible exchange. Consumers with questions may contact the
company via email to support@regeneca.com.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm
• Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company.